Format

Send to

Choose Destination
See comment in PubMed Commons below
J Comput Aided Mol Des. 2005 Dec;19(12):871-85. Epub 2006 May 12.

Protein farnesyltransferase: flexible docking studies on inhibitors using computational modeling.

Author information

1
Drug Discovery Program, H. Lee Moffitt Cancer Center & Research Institute, Department of Oncology, College of Medicine, University of South Florida, Tampa, FL 33612, USA. guidawc@moffitt.usf.edu

Abstract

Using MacroModel, peptide, peptidomimetic and non-peptidomimetic inhibitors of the zinc metalloenzyme, farnesyltransferase (FTase), were docked into the enzyme binding site. Inhibitor flexibility, farnesyl pyrophosphate substrate flexibility, and partial protein flexibility were taken into account in these docking studies. In addition to CVFM and CVIM, as well as our own inhibitors FTI-276 and FTI-2148, we have docked other farnesyltransferase inhibitors (FTIs) including Zarnestra, which presently is in advanced clinical trials. The AMBER* force field was employed, augmented with parameters that were derived for zinc. A single binding site model that was derived from the crystal structure of CVFM complexed with farnesyltransferase and farnesylpyrophosphate was used for these studies. The docking results using the lowest energy structure from the simulation, or one of the lowest energy structures, were generally in excellent agreement with the X-ray structures. One of the most important findings of this study is that numerous alternative conformations for the methionine side chain can be accommodated by the enzyme suggesting that the methionine pocket can tolerate groups larger than methionine at the C-terminus of the tetrapeptide and suggesting alternative locations for the placement of side chains that may improve potency.

PMID:
16607571
DOI:
10.1007/s10822-005-9030-2
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center